Ketoalfa Tablet contains Alpha Ketoanalogue 200 mg, a specialized compound used primarily as a nutritional supplement in the management of chronic kidney disease (CKD). Alpha Ketoanalogue serves as a nitrogen-free analog of essential amino acids, which, when administered, can be transaminated to form essential amino acids within the body. This mechanism helps reduce the accumulation of nitrogenous waste products, thereby alleviating uremic symptoms and slowing the progression of renal impairment. Ketoalfa is typically prescribed as an adjunct to a low-protein diet in patients with moderate to severe renal insufficiency to minimize protein catabolism and maintain nutritional status while reducing the burden on compromised kidneys. The tablet should be taken under medical supervision, with dosage tailored according to the patient’s renal function, dietary protein intake, and clinical condition. Commonly, Ketoalfa is used in conjunction with other therapeutic measures aimed at managing CKD, including blood pressure control and electrolyte balance. It is contraindicated in patients with hypersensitivity to any component of the formulation. Monitoring of serum electrolytes, renal function tests, and nutritional parameters is recommended during therapy to ensure efficacy and safety. Ketoalfa offers a valuable adjunctive approach in the multidisciplinary management of CKD to improve patient outcomes.